Navigation Links
BD Applauds PEPFAR's Broadened Emphasis on Strengthening Health Systems
Date:1/8/2010

FRANKLIN LAKES, N.J., Jan. 8 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has praised the recent announcement that the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) will increase its emphasis over the next five years on strengthening health systems in developing countries.

BD currently collaborates with PEPFAR on three separate initiatives that promote the long-term sustainability of healthcare delivery throughout sub-Saharan Africa. The programs focus on strengthening laboratory systems, protecting healthcare workers, and improving blood collection practices in the region.

On December 1, 2009, World AIDS Day, Ambassador Eric Goosby, the U.S. Global AIDS Coordinator, announced that the United States would launch a new five-year strategy that will move PEPFAR "from an emergency response to one of durable health systems that are designed to serve the medical needs of people with HIV/AIDS and the communities where they live," as reported in an article posted on the U.S. State Department's America.gov website.

"We're going to begin transitioning from an emergency response to a sustainable one through greater engagement with and capacity building of governments," said Ambassador Goosby.

Similarly, on November 30, 2009, Secretary of State Hillary Rodham Clinton said that PEPFAR's second five-year phase will witness a "transitioning from emergency response to sustainable health systems that help meet the broad medical needs of people with HIV and the communities in which they live."

"While emergency response remains essential to addressing the HIV/AIDS pandemic, the most viable and sustainable long-term approach for preventing, diagnosing, monitoring and treating HIV/AIDS and related opportunistic infections is to strengthen healthcare systems in developing countries," said Gary Cohen, Executive Vice President, BD. "This is why we agree with and support this area of strategic emphasis for PEPFAR."

BD's three public-private collaborations with PEPFAR are focused on different areas of health system strengthening. The laboratory strengthening program involves extensive training of laboratory technicians in quality control systems and specific testing procedures for diagnosing and monitoring HIV/AIDS and tuberculosis. The Wellness Center initiative, pursued in collaboration with the International Council of Nurses, provides essential services to health workers and their families including discreet HIV testing and treatment. Most recently, BD and PEPFAR announced the launch of a third program focused on safe blood sampling and handling practices. It is anticipated that as many as 10,000 health workers will be trained in this program.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

SOURCE BD-Becton Dickinson

RELATED LINKS
http://www.bd.com

'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. APHA Applauds Senate for Advancing Health Reform Bill
2. AARP Applauds Senate for Moving Health Care Reform Forward
3. AARP Maryland Applauds Senate for Moving Health Care Reform Forward
4. Rep. Fattah Applauds Senate Democrats on Healthcare
5. NAMI Applauds New Report on Caregiving
6. NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange
7. SNM applauds FDAs issuing of new drug manufacturing requirements
8. Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts
9. Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health
10. Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform
11. Wounded Warrior Project (WWP) Applauds the Senate for Passing Crucial Family Caregiver Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: